Aytu Biopharma, Inc
AYTU- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001385818
No open-market purchases or sales by Aytu Biopharma, Inc insiders were filed in the last 90 days; 38 institutions reported holding it in 13F filings for Q2 2026, worth $8.25M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Aytu Biopharma, Inc changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 72 | 61 | −11 |
| Shares | 6.37M | 5.18M | −1.18M (−18.6%) |
| Value | $48.4M | $26.0M | −$22.4M (−46.3%) |
New holders (13)
Institutions that held Aytu Biopharma, Inc at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 440,415 | $2.21M | 0.00% |
| Virtu Financial LLC | 101,805 | $510.0K | 0.05% |
| D. E. Shaw & Co., Inc. | 95,918 | $480.0K | 0.00% |
| Ergoteles LLC | 75,472 | $378.0K | 0.01% |
| Tibra Equities Europe Ltd | 60,100 | $301.0K | 0.09% |
| HRT Financial LP | 56,638 | $283.0K | 0.00% |
| ExodusPoint Capital Management, LP | 53,859 | $270.0K | 0.00% |
| Squarepoint Ops LLC | 34,487 | $173.0K | 0.00% |
| Jane Street Group, LLC | 15,720 | $78.0K | 0.00% |
| IFP Advisors, Inc | 200 | $1.00K | 0.00% |
| FMR LLC | 1 | $0 | 0.00% |
| SRS Capital Advisors, Inc. | 5 | $0 | 0.00% |
| Aspire Private Capital, LLC | 5 | $0 | 0.00% |
Sold out (24)
Institutions that held Aytu Biopharma, Inc at the end of Q1 2021 and filed for Q2 2021 without it.